
Peter Harwin & Tomas Kiselak: Biotech's New Builders - [Joys of Compounding, EP. 42]
AI summary Fairmount Funds co-founders Peter Harwin and Tomas Kiselak detail their transition from public market biotech investors to company builders who have founded 17 companies with a combined market cap exceeding $50 billion. Their strategy centers on identifying "reference…
- The Four Loves
- Biotechnology
- FDA
2 h 15 minEnglishSummary · Transcript








